Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-01-29 @ 9:49 AM
Study NCT ID:
NCT00865020
Status:
COMPLETED
Last Update Posted:
2011-07-22
First Post:
2009-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-17
First Submit QC Date:
None
Study First Post Date:
2009-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-06-22
Results First Submit QC Date:
None
Results First Post Date:
2011-07-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-22
Last Update Post Date:
2011-07-22
Last Update Post Date Type:
ESTIMATED